AUROBINDO PHARMA
Back to All Ratios
|
AUROBINDO PHARMA Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 14.39 | 13.76 | 9.39 | 12.71 | 30.10 |
What is the latest Return on Capital Employed (ROCE) ratio of AUROBINDO PHARMA ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 14.39 |
| Mar2024 | 13.76 |
| Mar2023 | 9.39 |
| Mar2022 | 12.71 |
| Mar2021 | 30.10 |
How is Return on Capital Employed (ROCE) of AUROBINDO PHARMA Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 14.39 | 4.58 | |
| Mar2024 | 13.76 | 46.54 | |
| Mar2023 | 9.39 | -26.12 | |
| Mar2022 | 12.71 | -57.77 | |
| Mar2021 | 30.1 | - | |
Other Financial Ratios of AUROBINDO PHARMA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹79,906.5 Cr | -1.7% | 5.8% | 14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -1.7% |
5.8% |
14.7% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses